Manon Allaire

Caen, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 118 publications

Implementation and evaluation of an ambulatory care pathway for intra-arterial treatment of primary liver cancer: study protocol for a multicentre randomised controlled hybrid type 1 trial (CHOC).

Implementation and evaluation of an ambulatory care pathway for intra-arterial treatment of primary liver cancer: study protocol for a multicentre randomised controlled hybrid type 1 trial (CHOC).

Journal: BMJ open

Published: August 06, 2026

ASO Visual Abstract: AFP Model Predicts Outcomes after Liver Resection: a Multicenter Retrospective Cohort Study.

ASO Visual Abstract: AFP Model Predicts Outcomes after Liver Resection: a Multicenter Retrospective Cohort Study.

Journal: Annals of surgical oncology

Published: June 02, 2026

Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach.

Cirrhosis, portal hypertension and hepatocellular carcinoma: a stage-based approach.

Journal: Nature reviews. Gastroenterology & hepatology

Published: April 07, 2026

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

Baseline circulating and tumor γδ T cells and early circulating CD8⁺PD1⁺ expansion predict response to Atezolizumab-bevacizumab in HCC.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: March 24, 2026

Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.

Atezolizumab-bevacizumab in very elderly with hepatocellular carcinoma: Age alone is not a limiting factor except in ALBI grade 3.

Journal: JHEP reports : innovation in hepatology

Published: February 16, 2026

AFP Model Predicts Outcomes After Liver Resection: A Multicenter Retrospective Cohort Study.

AFP Model Predicts Outcomes After Liver Resection: A Multicenter Retrospective Cohort Study.

Journal: Annals of surgical oncology

Published: February 03, 2026

Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Clinical impact of extrahepatic metastatic patterns in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 14, 2026

Hepatocellular carcinoma with macrovascular invasion: Navigating heterogeneous evidence.

Hepatocellular carcinoma with macrovascular invasion: Navigating heterogeneous evidence.

Journal: Hepatology (Baltimore, Md.)

Published: January 02, 2026

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to Atezolizumab-bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: December 29, 2025

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Clinical predictors of response to atezolizumab/bevacizumab in Child-Pugh B patients with hepatocellular carcinoma.

Journal: JHEP reports : innovation in hepatology

Published: December 29, 2025

Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis.

Second-line TKI after first-line immunotherapy-based treatment in advanced HCC: Reconstructed IPD meta-analysis.

Journal: JHEP reports : innovation in hepatology

Published: December 16, 2025

Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.

Serum Procalcitonin: A Novel Tumor Biomarker for Diagnosis and Follow-Up in Fibrolamellar Hepatocellular Carcinoma.

Journal: medRxiv : the preprint server for health sciences

Published: December 03, 2025

Showing 1-12 of 118

Last Updated: 09/26/2026